CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 100.0%

Compliant submissions 2

Incompliant submissions 0

Total trials 2

My Organizations' Clinical Trials

Showing 750 of 2003 entries

View as:

Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2

Phase: N/A Priority: Normal

NCT ID: NCT00544804 Org: User:

Start: 08/31/07 End: 12/31/13 Due: 12/31/14

Applying Mobile Persuasive Technologies to Increase Physical Activity in Women

Phase: N/A Priority: Normal

NCT ID: NCT01280812 Org: User:

Start: 02/28/11 End: 04/30/15 Due: 04/30/16

Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients

Phase: N/A Priority: Normal

NCT ID: NCT06798909 Org: User:

Start: 06/28/25 End: 06/30/31 Due: 06/30/32

Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial

Phase: N/A Priority: Normal

NCT ID: NCT03508830 Org: User:

Start: 12/30/18 End: 01/30/21 Due: 01/30/22

Pilot Trial of a Game Embedded in a Smartphone App for Smoking Cessation

Phase: N/A Priority: Normal

NCT ID: NCT05227027 Org: User:

Start: 02/09/22 End: 05/31/22 Due: 05/31/23

Acupuncture and Post-Surgical Wound Healing

Phase: N/A Priority: Normal

NCT ID: NCT00260494 Org: User:

Start: 03/31/05 End: 07/31/06 Due: 07/31/07

The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk

Phase: N/A Priority: Normal

NCT ID: NCT01333644 Org: User:

Start: 04/30/10 End: 12/31/14 Due: 12/31/15

Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT00023621 Org: User:

Start: 02/28/01 End: 07/31/07 Due: 07/31/08

Dexmedetomidine in Seizure Patients

Phase: N/A Priority: Normal

NCT ID: NCT01116700 Org: User:

Start: 12/31/10 End: 02/29/12 Due: 02/28/13

This is an Observational Pre-post Study to Observe if the Off Label Use of Anti-IL1 Therapies, Such as Anakinra or Canakinumab, Can Block ACVR1-induced Flare Activity and Heterotopic Ossification in FOP

Phase: N/A Priority: Normal

NCT ID: NCT06724562 Org: User:

Start: 04/01/25 End: 03/31/27 Due: 03/31/28

Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced Cancer

Phase: N/A Priority: Normal

NCT ID: NCT04697524 Org: User:

Start: 01/26/21 End: 05/31/23 Due: 05/31/24

Transseptal Needle Versus Radiofrequency Energy for Left Atrial Access

Phase: N/A Priority: Normal

NCT ID: NCT01209260 Org: User:

Start: 11/30/10 End: 11/30/12 Due: 11/30/13

Trial Evaluating Use of Arista in Total Thyroidectomy

Phase: N/A Priority: Normal

NCT ID: NCT02568085 Org: User:

Start: 03/31/16 End: 06/30/17 Due: 06/30/18

Packing Versus no Packing for Cutaneous Abscess

Phase: N/A Priority: Normal

NCT ID: NCT02822768 Org: User:

Start: 08/31/16 End: 04/30/24 Due: 04/30/25

Care Ecosystem: Navigating Patients and Families Through Stages of Care

Phase: N/A Priority: Normal

NCT ID: NCT02213458 Org: User:

Start: 03/20/15 End: 03/08/18 Due: 03/08/19

FACE-PC: Family-Centered Care for Older Adults With Depression and Chronic Medical Conditions in Primary Care

Phase: N/A Priority: Normal

NCT ID: NCT03094871 Org: User:

Start: 04/01/15 End: 12/30/20 Due: 12/30/21

Validation of Dietary Calcium Questionnaires Using Diet Records

Phase: N/A Priority: Normal

NCT ID: NCT00512733 Org: User:

Start: 03/31/06 End: 03/31/08 Due: 03/31/09

Early HIV Therapy in Patients With High CD4 Cell Counts

Phase: N/A Priority: Normal

NCT ID: NCT01479634 Org: User:

Start: 10/31/11 End: 06/30/15 Due: 06/30/16

Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00301951 Org: User:

Start: 09/30/04 End: 07/31/09 Due: 07/31/10

Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort

Phase: N/A Priority: Normal

NCT ID: NCT06078527 Org: User:

Start: 06/01/25 End: 01/31/27 Due: 01/31/28

Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM)

Phase: N/A Priority: Normal

NCT ID: NCT00670956 Org: User:

Start: 04/30/08 End: 09/30/11 Due: 09/30/12

Exercise for Cognitive Excellence in Parkinson's Disease

Phase: N/A Priority: Normal

NCT ID: NCT05720468 Org: User:

Start: 07/20/23 End: 01/31/26 Due: 01/31/27

Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya

Phase: N/A Priority: Normal

NCT ID: NCT05351606 Org: User:

Start: 05/16/23 End: 09/30/25 Due: 09/30/26

A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain

Phase: N/A Priority: Normal

NCT ID: NCT05010148 Org: User:

Start: 09/17/21 End: 09/30/27 Due: 09/30/28

Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in Mexico and Puerto Rico

Phase: N/A Priority: Normal

NCT ID: NCT05074264 Org: User:

Start: 11/30/21 End: 12/31/27 Due: 12/31/28

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2	NCT00544804	University of California, San Francisco	user2@example.com	None	2007-08-31	2013-12-31	2014-12-31	-	-	2025-07-14
Applying Mobile Persuasive Technologies to Increase Physical Activity in Women	NCT01280812	University of California, San Francisco	user2@example.com	None	2011-02-28	2015-04-30	2016-04-30	-	-	2025-07-14
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients	NCT06798909	University of California, San Francisco	user2@example.com	None	2025-06-28	2031-06-30	2032-06-30	-	-	2025-07-14
Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial	NCT03508830	University of California, San Francisco	user2@example.com	None	2018-12-30	2021-01-30	2022-01-30	-	-	2025-07-14
Pilot Trial of a Game Embedded in a Smartphone App for Smoking Cessation	NCT05227027	University of California, San Francisco	user2@example.com	None	2022-02-09	2022-05-31	2023-05-31	-	-	2025-07-14
Acupuncture and Post-Surgical Wound Healing	NCT00260494	University of California, San Francisco	user2@example.com	None	2005-03-31	2006-07-31	2007-07-31	-	-	2025-07-14
The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk	NCT01333644	University of California, San Francisco	user2@example.com	None	2010-04-30	2014-12-31	2015-12-31	-	-	2025-07-14
Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome	NCT00023621	University of California, San Francisco	user2@example.com	None	2001-02-28	2007-07-31	2008-07-31	-	-	2025-07-14
Dexmedetomidine in Seizure Patients	NCT01116700	University of California, San Francisco	user2@example.com	None	2010-12-31	2012-02-29	2013-02-28	-	-	2025-07-14
This is an Observational Pre-post Study to Observe if the Off Label Use of Anti-IL1 Therapies, Such as Anakinra or Canakinumab, Can Block ACVR1-induced Flare Activity and Heterotopic Ossification in FOP	NCT06724562	University of California, San Francisco	user2@example.com	None	2025-04-01	2027-03-31	2028-03-31	-	-	2025-07-14
Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced Cancer	NCT04697524	University of California, San Francisco	user2@example.com	None	2021-01-26	2023-05-31	2024-05-31	-	-	2025-07-14
Transseptal Needle Versus Radiofrequency Energy for Left Atrial Access	NCT01209260	University of California, San Francisco	user2@example.com	None	2010-11-30	2012-11-30	2013-11-30	-	-	2025-07-14
Trial Evaluating Use of Arista in Total Thyroidectomy	NCT02568085	University of California, San Francisco	user2@example.com	None	2016-03-31	2017-06-30	2018-06-30	-	-	2025-07-14
Packing Versus no Packing for Cutaneous Abscess	NCT02822768	University of California, San Francisco	user2@example.com	None	2016-08-31	2024-04-30	2025-04-30	-	-	2025-07-14
Care Ecosystem: Navigating Patients and Families Through Stages of Care	NCT02213458	University of California, San Francisco	user2@example.com	None	2015-03-20	2018-03-08	2019-03-08	-	-	2025-07-14
FACE-PC: Family-Centered Care for Older Adults With Depression and Chronic Medical Conditions in Primary Care	NCT03094871	University of California, San Francisco	user2@example.com	None	2015-04-01	2020-12-30	2021-12-30	-	-	2025-07-14
Validation of Dietary Calcium Questionnaires Using Diet Records	NCT00512733	University of California, San Francisco	user2@example.com	None	2006-03-31	2008-03-31	2009-03-31	-	-	2025-07-14
Early HIV Therapy in Patients With High CD4 Cell Counts	NCT01479634	University of California, San Francisco	user2@example.com	None	2011-10-31	2015-06-30	2016-06-30	-	-	2025-07-14
Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer	NCT00301951	University of California, San Francisco	user2@example.com	None	2004-09-30	2009-07-31	2010-07-31	-	-	2025-07-14
Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort	NCT06078527	University of California, San Francisco	user2@example.com	None	2025-06-01	2027-01-31	2028-01-31	-	-	2025-07-14
Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM)	NCT00670956	University of California, San Francisco	user2@example.com	None	2008-04-30	2011-09-30	2012-09-30	-	-	2025-07-14
Exercise for Cognitive Excellence in Parkinson's Disease	NCT05720468	University of California, San Francisco	user2@example.com	None	2023-07-20	2026-01-31	2027-01-31	-	-	2025-07-14
Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya	NCT05351606	University of California, San Francisco	user2@example.com	None	2023-05-16	2025-09-30	2026-09-30	-	-	2025-07-14
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain	NCT05010148	University of California, San Francisco	user2@example.com	None	2021-09-17	2027-09-30	2028-09-30	-	-	2025-07-14
Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in Mexico and Puerto Rico	NCT05074264	University of California, San Francisco	user2@example.com	None	2021-11-30	2027-12-31	2028-12-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance